Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MC4R | P32245 | 6/20 | 0.55 |
| ▸ | IL23R | Q5VWK5 | 10/20 | 0.51 |
| ▸ | NPBWR1 | P48145 | 1/20 | 0.51 |
| ▸ | KISS1R | Q969F8 | 2/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26421988 | 0.93 | NPBWR1 (0.52) | MC4RIL23RNPBWR1KISS1R | |
| SCHEMBL24919242 | 0.92 | NPBWR1 (0.49) | MC4RNPBWR1KISS1R | |
| SCHEMBL23417784 | 0.92 | MC4R (0.58) | MC4RIL23RNPBWR1KISS1R | |
| SCHEMBL26421705 | 0.86 | CTSL (0.52) | MC4RIL23R | |
| SCHEMBL26421690 | 0.86 | CTSL (0.52) | MC4RIL23R | |
| SCHEMBL22803171 | 0.86 | PRMT1 (0.54) | MC4RIL23RNPBWR1KISS1R | |
| SCHEMBL23417874 | 0.86 | MC4R (0.52) | MC4RIL23RNPBWR1 | |
| SCHEMBL28235858 | 0.85 | ACE (0.57) | MC4R | |
| SCHEMBL23417933 | 0.85 | NPBWR1 (0.52) | MC4RIL23RNPBWR1KISS1R | |
| SCHEMBL20694561 | 0.85 | PRMT1 (0.54) | MC4RNPBWR1KISS1R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230128688-A1 | DIRECTED CONJUGATION TECHNOLOGIES | KLEO PHARMACEUTICALS, INC. | 2023-04-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230128688-A1 | DIRECTED CONJUGATION TECHNOLOGIES | CD2BP2, CD2, CD47 | MC4R 4124/4885IL23R 2886/4885NPBWR1 3691/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.